HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective anti-endothelial effects of protracted low-dose BAL-9504, a novel geranylgeranyl-transferase inhibitor.

Abstract
Because the anti-endothelial effects of agents such as interferon alpha, endostatin, and various chemotherapeutic drugs appear to be optimal after protracted, frequent dosing, both in vitro and in vivo, using low concentrations/doses of drugs, we tested the geranylgeranyl transferase inhibitor BAL-9504 ((E,E,E) [2-oxo-2-[[(3,7,11,15-tetramethyl-2,6,10,14 hexadecatetraenyl)-oxy]amino]ethyl] phosphonic acid) in this manner on different human cell types, including endothelial, breast cancer cells and fibroblasts. We found that human endothelial cells were preferentially affected with respect to inhibition of proliferation, induction of apoptosis, suppression of adhesion to fibronectin, and blockade of cell migration, by daily exposure to low concentrations of BAL-9504 for 6 days. These results may have implications in terms of both increasing anti-tumor efficacy, mediated by antiangiogenic mechanisms, and reducing toxic side effects.
AuthorsGuido Bocci, Romano Danesi, Mario Del Tacca, Robert S Kerbel
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 477 Issue 1 Pg. 17-21 (Sep 05 2003) ISSN: 0014-2999 [Print] Netherlands
PMID14512093 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiogenesis Inhibitors
  • BAL 9504
  • Fibronectins
  • Organophosphonates
  • Alkyl and Aryl Transferases
  • geranylgeranyltransferase type-I
Topics
  • Alkyl and Aryl Transferases (antagonists & inhibitors)
  • Angiogenesis Inhibitors (administration & dosage, pharmacology)
  • Apoptosis (drug effects)
  • Cell Adhesion (drug effects)
  • Cell Division (drug effects)
  • Cell Movement (drug effects)
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Endothelial Cells (cytology, drug effects, enzymology)
  • Endothelium, Vascular (cytology, drug effects, enzymology)
  • Fibronectins (chemistry)
  • Humans
  • Organophosphonates (administration & dosage, pharmacology)
  • Umbilical Cord (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: